Sartorius will manufacture bioreactors and further production equipment for customers in the biopharmaceutical industry at the new 100,000ft² plant.
State Government of Hesse Prime Minister Volker Bouffier said, "We offer companies an excellent infrastructure and intentionally promote the regional economy so that innovative medium-sized companies will invest in and stay with us."
Sartorius has rented the new building complex which provides space for a high-tech manufacturing hall and offices for around 240 employees in a long-term lease from Robos, the building owner.
The company has moved from its previous bioreactor production facility in Melsungen, Germany, where it had reached maximum capacity limits.
Sartorius CEO and executive board chairman Joachim Kreuzburg said the new plant enables the company to substantially enhance its manufacturing processes and creates additional capacity in view of the rising demand for biopharmaceutical production equipment.
"As a result, we are optimally prepared for further expansion, especially for single-use bioreactors," Kreuzburg added.